COVID-19 in solid organ transplantation: a matched retrospective cohort study and evaluation of immunosuppression management
…, A Antón, B Montoro, MQ Gorgas-Torner - …, 2021 - journals.lww.com
Background. The epidemiological and clinical characteristics of solid organ transplant (SOT)
patients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
patients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Safety of tocilizumab in COVID‐19 pregnant women and their newborn: a retrospective study
…, A Suy, MQ Gorgas Torner - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Tocilizumab is an IL‐6 receptor inhibitor agent which has been
proposed as a candidate to stop the inflammatory phase of infection by the severe acute …
proposed as a candidate to stop the inflammatory phase of infection by the severe acute …
Incident study of medication errors in drug use processes: prescription, transcription, validation, preparation, dispensing, and administering in the hospital environment
…, JA Schönenberger-Arnaiz, MQ Gorgas-Torner… - Farmacia Hospitalaria …, 2009 - Elsevier
Objective To determine both the global incident, and the incident for stages of medication
errors in 6 Catalonian hospitals, the types of error, and the consequences. Method A …
errors in 6 Catalonian hospitals, the types of error, and the consequences. Method A …
[HTML][HTML] Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus statement. Practice guidelines of the …
…, E González-Haba, MQ Gorgas-Torner… - Farmacia …, 2021 - Elsevier
Objective To establish a series of recommendations based on available evidence for
monitoring surface contamination in the areas devoted to compounding hazardous drugs in …
monitoring surface contamination in the areas devoted to compounding hazardous drugs in …
[HTML][HTML] Estudio de incidencia de los errores de medicación en los procesos de utilización del medicamento: prescripción, transcripción, validación, preparación …
…, JA Schönenberger-Arnaiz, MQ Gorgas-Torner… - Farmacia …, 2009 - Elsevier
Objetivo Determinar la incidencia global y por etapas de los errores de medicación en 6
hospitales de Cataluña, así como los tipos de error y las consecuencias. Método Diseño …
hospitales de Cataluña, así como los tipos de error y las consecuencias. Método Diseño …
Association between postnatal weight gain and need for treatment in retinopathy of prematurity
…, S Clemente Bautista, MQ Gorgas Torner - The Journal of …, 2022 - Taylor & Francis
Objective To study the association between gestational age (GA) and weight at birth and the
development of retinopathy of prematurity (ROP), and in particular the link between …
development of retinopathy of prematurity (ROP), and in particular the link between …
The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic …
…, H Colom, MJ Cabañas-Poy, MQ Gorgas-Torner… - Pediatric Drugs, 2024 - Springer
Background Therapeutic drug monitoring (TDM) of infliximab has been shown to be a
effective strategy for inflammatory bowel disease (IBD). Population pharmacokinetic …
effective strategy for inflammatory bowel disease (IBD). Population pharmacokinetic …
Pharmaceutical care for drug-related problems in inpatients
GT MQ - Farmacia Hospitalaria: Organo Oficial de Expresion …, 2003 - europepmc.org
Methods DRPs detected during 6 months at Hospital Comarcal de Sant Bernabé were
recorded and classified, and their severity established. Pharmaceutical intervention was …
recorded and classified, and their severity established. Pharmaceutical intervention was …
[PDF][PDF] Atención farmacéutica en los problemas relacionados con los medicamentos en enfermos hospitalizados
MQG Torner, EO Estradé, FP Solernou - Farmacia Hospitalaria, 2003 - sefh.es
La elevada morbilidad de la farmacoterapia implica que el farmacéutico participe en la
prevención y resolución de problemas relacionados con medicamentos (PRM). Objetivo …
prevención y resolución de problemas relacionados con medicamentos (PRM). Objetivo …
[HTML][HTML] Programa de atención farmacéutica integrada en pacientes con enfermedades crónicas
MQG Torner, FP Vives, JC Ramió… - Farmacia …, 2012 - Elsevier
Objetivo Valorar si un programa de atención farmacéutica integrada (PAFI) en pacientes
crónicos mejora la evolución clínica, la calidad de vida de los pacientes y disminuye el …
crónicos mejora la evolución clínica, la calidad de vida de los pacientes y disminuye el …